MYRIAD GENETICS INC Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Myriad Genetics Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Myriad Genetics Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $900K, a 800% increase year-over-year.
  • Myriad Genetics Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$600K, a 92.1% increase year-over-year.
  • Myriad Genetics Inc annual Income Tax Expense (Benefit) for 2023 was $1.1M.
  • Myriad Genetics Inc annual Income Tax Expense (Benefit) for 2022 was -$28.6M, a 4.35% increase from 2021.
  • Myriad Genetics Inc annual Income Tax Expense (Benefit) for 2021 was -$29.9M, a 50.1% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$600K $900K +$800K +800% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$1.4M -$500K -$500K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$900K $100K -$2M -95.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.1M -$1.1M +$8.7M +88.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$7.6M $100K +$9.2M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$16.8M $0 +$3.8M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$20.6M $2.1M +$8M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$28.6M -$9.8M +$26.1M +72.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$54.7M -$9.1M -$24.3M -160% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$30.4M -$3.8M -$4.7M -522% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$25.7M -$5.9M +$4.2M +41.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$29.9M -$35.9M -$23.4M -187% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$6.5M $15.2M +$43.7M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$50.2M $900K +$3.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$54.1M -$10.1M +$5.8M +36.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$59.9M -$12.5M -$9.4M -303% Oct 1, 2020 Dec 31, 2020 10-KT 2021-03-16
Q3 2020 -$50.5M -$28.5M -$26.8M -1576% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$23.7M -$3M +$400K +11.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$24.1M -$15.9M -$12.3M -342% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$11.8M -$3.1M -$4.1M -410% Oct 1, 2019 Dec 31, 2019 10-KT 2021-03-16
Q3 2019 -$7.7M -$1.7M -$3.3M -206% Jul 1, 2019 Sep 30, 2019 10-KT 2021-03-16
Q2 2019 -$4.4M -$3.4M -$6.9M -197% Apr 1, 2019 Jun 30, 2019 10-KT 2021-03-16
Q1 2019 $2.5M -$3.6M -$7.9M -184% Jan 1, 2019 Mar 31, 2019 10-KT 2021-03-16
Q4 2018 $10.4M $1M +$26.3M Oct 1, 2018 Dec 31, 2018 10-KT 2021-03-16
Q3 2018 -$15.9M $1.6M -$2.9M -64.4% Jul 1, 2018 Sep 30, 2018 10-KT 2021-03-16
Q2 2018 -$13M $3.5M -$2.3M -39.7% Apr 1, 2018 Jun 30, 2018 10-K 2019-08-13
Q1 2018 -$10.7M $4.3M +$1.3M +43.3% Jan 1, 2018 Mar 31, 2018 10-K 2019-08-13
Q4 2017 -$12M -$25.3M -$31.5M -508% Oct 1, 2017 Dec 31, 2017 10-K 2019-08-13
Q3 2017 $19.5M $4.5M -$1.1M -19.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-08-13
Q2 2017 $20.6M $5.8M -$3.3M -36.3% Apr 1, 2017 Jun 30, 2017 10-K 2018-08-24
Q1 2017 $23.9M $3M -$5.6M -65.1% Jan 1, 2017 Mar 31, 2017 10-K 2018-08-24
Q4 2016 $29.5M $6.2M -$1.7M -21.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-08-24
Q3 2016 $31.2M $5.6M -$7.6M -57.6% Jul 1, 2016 Sep 30, 2016 10-K 2018-08-24
Q2 2016 $38.8M $9.1M -$7.5M -45.2% Apr 1, 2016 Jun 30, 2016 10-K 2018-08-24
Q1 2016 $46.3M $8.6M -$5.5M -39% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $51.8M $7.9M -$6M -43.2% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-08
Q3 2015 $57.8M $13.2M +$3.3M +33.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $54.5M $16.6M -$2.28M -12.1% Apr 1, 2015 Jun 30, 2015 10-K 2018-08-24
Q1 2015 $56.8M $14.1M -$6.47M -31.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 $63.3M $13.9M -$19.9M -58.9% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-03
Q3 2014 $83.1M $9.9M -$18.5M -65.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $102M $18.9M -$4.24M -18.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-08-10
Q1 2014 $106M $20.6M -$776K -3.64% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $107M $33.8M +$11.8M +53.9% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-04
Q3 2013 $94.8M $28.4M +$8.68M +44.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $86.1M $23.1M +$3.79M +19.6% Apr 1, 2013 Jun 30, 2013 10-K 2015-08-12
Q1 2013 $82.3M $21.3M +$3.48M +19.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $78.8M $21.9M +$3.46M +18.7% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-05
Q3 2012 $75.4M $19.7M +$2.98M +17.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $72.4M $19.3M +$3.26M +20.3% Apr 1, 2012 Jun 30, 2012 10-K 2014-08-13
Q1 2012 $69.1M $17.9M +$3.49M +24.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $65.6M $18.5M +$3.62M +24.4% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-06
Q3 2011 $62M $16.7M +$3.07M +22.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $58.9M $16.1M Apr 1, 2011 Jun 30, 2011 10-K 2013-08-14
Q1 2011 $14.4M +$13.1M +1069% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-02
Q4 2010 $14.9M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-01
Q3 2010 $13.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-02
Q1 2010 $1.23M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.